The EU’s Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted a positive opinion recommending marketing of NovoRapid PumpCart in Europe. NovoRapid PumpCart is a 1.6 ml prefilled insulin pump cartridge containing the rapid-acting insulin NovoRapid, marketed in the U.S. as Novolog (insulin aspart [rDNA origin] injection), from Novo Nordisk. It is compatible with Roche Diabetes Care’s next-generation Accu-Chek Insight diabetes therapy system.
NovoRapid PumpCart has been developed in a non-exclusive partnership between Roche Diabetes Care, to simplify the process insulin pump users go through when they need to refill their pump with insulin (a procedure which insulin pump users do every 3-4 days). The cartridge was designed for use with the new Accu-Chek Insight insulin pump.
NovoRapid PumpCart is currently expected to be launched in selected European countries during 2014 and 2015.
